# Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee

> **NCT06021444** · NA · COMPLETED · sponsor: **Dongkook Pharmaceutical Co., Ltd.** · enrollment: 250 (actual)

## Conditions studied

- Osteoarthritis of Knee

## Interventions

- **DEVICE:** DKM420
- **DEVICE:** Conjuran

## Key facts

- **NCT ID:** NCT06021444
- **Lead sponsor:** Dongkook Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-30
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-07-18
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06021444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06021444, "Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06021444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*